Zobrazeno 1 - 10
of 44
pro vyhledávání: '"Peter Hammarsten"'
Autor:
Peter Hammarsten, Tove Dahl Scherdin, Christina Hägglöf, Pernilla Andersson, Pernilla Wikström, Pär Stattin, Lars Egevad, Torvald Granfors, Anders Bergh
Publikováno v:
PLoS ONE, Vol 11, Iss 10, p e0164016 (2016)
In the present study we have investigated whether Caveolin-1 expression in non-malignant and malignant prostate tissue is a potential prognostic marker for outcome in prostate cancer patients managed by watchful waiting. Caveolin-1 was measured in pr
Externí odkaz:
https://doaj.org/article/19fc74e6826340bcac466bc8024e3e45
Autor:
Maria Nilsson, Christina Hägglöf, Peter Hammarsten, Elin Thysell, Pär Stattin, Lars Egevad, Torvald Granfors, Emma Jernberg, Pernilla Wikstrom, Sofia Halin Bergström, Anders Bergh
Publikováno v:
PLoS ONE, Vol 10, Iss 10, p e0140985 (2015)
Lysyl oxidase (LOX) has been shown to both promote and suppress tumor progression, but its role in prostate cancer is largely unknown. LOX immunoreactivity was scored in prostate tumor epithelium, tumor stroma and in the tumor-adjacent non-malignant
Externí odkaz:
https://doaj.org/article/a3abacd574194e6c88dd8d66a3ef94f0
Autor:
Christina Hägglöf, Peter Hammarsten, Kerstin Strömvall, Lars Egevad, Andreas Josefsson, Pär Stattin, Torvald Granfors, Anders Bergh
Publikováno v:
PLoS ONE, Vol 9, Iss 2, p e86824 (2014)
The TMPRSS2-ERG gene fusion is found in approximately half of all prostate cancers. The functional and prognostic significance of TMPRSS2-ERG is, however, not fully understood. Based on a historical watchful waiting cohort, an association between TMP
Externí odkaz:
https://doaj.org/article/9eb98ac4e4cd46a890cfeecdc062fb3a
Autor:
Peter Hammarsten, Johanna Winther, Stina H Rudolfsson, Jenny Häggström, Amar Karalija, Lars Egevad, Torvald Granfors, Christopher J Fowler
Publikováno v:
PLoS ONE, Vol 9, Iss 9, p e105063 (2014)
BACKGROUND: ErbB2 is a member of the epidermal growth factor family of tyrosine kinases that is centrally involved in the pathogenesis of prostate cancer and several studies have reported that a high expression of this protein has prognostic value. I
Externí odkaz:
https://doaj.org/article/df9a55769049467b84881535da131c95
Publikováno v:
PLoS ONE, Vol 8, Iss 6, p e65798 (2013)
BACKGROUND: In prostate cancer, tumour expression of cannabinoid CB₁ receptors is associated with a poor prognosis. One explanation for this association comes from experiments with transfected astrocytoma cells, where a high CB receptor expression
Externí odkaz:
https://doaj.org/article/a82aca07955b438e864c13be44dad792
Autor:
Peter Hammarsten, Mariateresa Cipriano, Andreas Josefsson, Pär Stattin, Lars Egevad, Torvald Granfors, Christopher J Fowler
Publikováno v:
PLoS ONE, Vol 7, Iss 10, p e47994 (2012)
BACKGROUND: In the present study, we have investigated the prognostic usefulness of phosphorylated Akt immunoreactivity (pAkt-IR) in prostate cancer using a well-characterised tissue microarray from men who had undergone transurethral resection due t
Externí odkaz:
https://doaj.org/article/2a49527a7f55476483896aceb2e492a2
Autor:
Lina Thors, Anders Bergh, Emma Persson, Peter Hammarsten, Pär Stattin, Lars Egevad, Torvald Granfors, Christopher J Fowler
Publikováno v:
PLoS ONE, Vol 5, Iss 8, p e12275 (2010)
Recent data have indicated that there may be a dysregulation of endocannabinoid metabolism in cancer. Here we have investigated the expression of the endocannabinoid metabolising enzyme fatty acid amide hydrolase (FAAH) in a well characterised tissue
Externí odkaz:
https://doaj.org/article/dd68bec98f0b469a8deb832eca469212
Autor:
Christina Hägglöf, Peter Hammarsten, Andreas Josefsson, Pär Stattin, Janna Paulsson, Anders Bergh, Arne Ostman
Publikováno v:
PLoS ONE, Vol 5, Iss 5, p e10747 (2010)
BACKGROUND: The identification of new prognostic markers for prostate cancer is highly warranted, since it is difficult to identify patients requiring curative treatment. Data from both experimental models and clinical samples have identified importa
Externí odkaz:
https://doaj.org/article/f8c92d3782de4637af9dd2a002e4add8
Publikováno v:
PLoS ONE, Vol 5, Iss 12, p e15205 (2010)
BACKGROUND: In cultured prostate cancer cells, down-regulation of epidermal growth factor receptor (EGFR) has been implicated in mediating the antiproliferative effect of the endogenous cannabinoid (CB) ligand anandamide. Using a well-characterised c
Externí odkaz:
https://doaj.org/article/8d5d9f697bf649fb8159d8ef72f1102d
Autor:
Anders Bergh, Pär Stattin, Torvald Granfors, Lars Egevad, Pernilla Wikström, Stina Häggström Rudolfsson, Andreas Josefsson, Amar Karalija, Peter Hammarsten
Supplementary Data from Low Levels of Phosphorylated Epidermal Growth Factor Receptor in Nonmalignant and Malignant Prostate Tissue Predict Favorable Outcome in Prostate Cancer Patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::87047bdd95e4633cedf87f8140da47ce
https://doi.org/10.1158/1078-0432.22440657.v1
https://doi.org/10.1158/1078-0432.22440657.v1
